tradearcher

(D) A bit early to consider long, esp. with earnings near.

NASDAQ:BLUE   bluebird bio, Inc.
Slope of ema50 is nearly flat and ema200 is mildly bearish, meaning price action at a possible inflection point near earnings. Will see $55 if bullish momentum continues. Otherwise retesting March lows for support is within it's ATR. Obey your rules.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.